Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
7680699740017
CH-69974
L04AC16
07.15.0.
google
Details
- Product number
- 6997401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- guselkumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, dinatrii edetas corresp. natrium 0.05 mg, aqua ad iniectabile q.s. ad solutionem pro 20 ml.
Articles (1)
Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.05 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4163.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2025
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69974
- Drug name
- Tremfya, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AC16
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/06/2025
- Authorization expiration date
- 09/06/2030
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TREMFYA 200 mg/20 ml conc perf 200 mg 1 pce
- Description (DE)
- TREMFYA 200 mg/20 ml Konz Inf 200 mg 1 Stk
- Market launch
- 29/07/2025
- Narcotic (BTM)
- No